低垂体和心血管风险的低垂体症
Ivana Kraljević1,2, Mirsala Solak2, Ante Mandić3,4
1School of Medicine, University of Zagreb, Zagreb, Croatia.
低位症会增加由于荷尔蒙缺乏和代谢问题的心血管风险. 优化激素替代疗法 (HRT) 可能会降低这种风险并改善患者的治疗结果.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
背景情况:
- 垂体下垂体 (hypopituitarism) 是一种垂体激素缺乏症,与较高的心血管 (CV) 发病率和死亡率有关.
- 它会导致代谢失调 (胰岛素耐药性,脂质不良,内脏脂肪) 和炎症,增加心血管疾病 (CVD) 的风险.
- 标准的激素替代疗法 (HRT) 可以产生不良的代谢效应,可能使动脉样硬化恶化.
研究的目的:
- 审查下垂体病的原因和心血管风险机制.
- 分析治疗策略以减轻心血管疾病发病率和死亡率.
主要方法:
- 综合性文献综述,重点关注病因学,病理生理学和心血管风险治疗的hypopituitarism.
主要成果:
- 低位症导致多种内分泌缺陷,促进代谢综合征和心血管疾病.
- 慢性炎症和内皮功能障碍是心血管风险升高的关键因素.
- 优化HRT,特别是生长激素和皮质醇,在降低心血管风险方面显示出希望.
结论:
- 低位症通过复杂的病理生理路径显著提高心血管风险.
- 量身定制的激素替代疗法和代谢因素的管理对于改善心血管结果至关重要.
更多相关视频
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Hypoglycemia and Glucagon
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
